The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

RESVIA is now authorized for use in adults aged 18–59 years with an increased risk of respiratory syncytial virus-related ...

Staff who provide data to the vaccine panel have been pushed aside, according to health officials, raising doubts about the ...

FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.

Secretary of Health and Human Services Robert F. Kennedy Jr.'s appearance this week on Fox News was so chockfull of ...

At the ongoing International Society for Stem Cell Research meeting, Chinese researchers reported they demonstrated that SPT6 homolog, histone chaperone and transcription elongation factor (SPT6) ...

Helen Chu, MD, urged doctors to find "science-based recommendations" from the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the American Academy of ...